gvtcx

Skin Cleansing and Disinfection

NHS Supply Chain Published 31 Jan 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£94,750,000
Statuscomplete
Category (CPV) 33000000 +17 more
RegionLondon
Deadline29 Apr 2021
Procedureopen
OCIDocds-h6vhtk-02a0af

Awards (56)

This procurement was awarded to 34 suppliers. Values shown are per-award; the notice total is £94,750,000.

SupplierValueDateStatus
3M United Kingdom Public Limited Company shared £94,750,000 17 Dec 2021 active
3M United Kingdom Public Limited Company shared · · active
Banner Group Limited shared £94,750,000 17 Dec 2021 active
Banner Group Limited shared · · active
B. Braun Medical Limited shared £94,750,000 17 Dec 2021 active
B. Braun Medical Limited shared · · active
Bio-Tech Solutions Limited shared £94,750,000 17 Dec 2021 active
Bio-Tech Solutions Limited shared · · active
Bunzl Retail & Healthcare Supplies Limited shared · · active
Bunzl Retail & Healthcare Supplies Limited Trading as 365 He shared £94,750,000 17 Dec 2021 active
Cod Beck Blenders Limited shared £94,750,000 17 Dec 2021 active
Cod Beck Blenders Limited shared · · active
Ecolab Limited trading as Ecolab Healthcare shared · · active
Ecolab Limited Trading as Ecolab Healthcare shared £94,750,000 17 Dec 2021 active
Gama Healthcare Ltd shared £94,750,000 17 Dec 2021 active
Gama Healthcare Ltd shared · · active
IMS Euro Limited shared £94,750,000 17 Dec 2021 active
IMS Euro Limited shared · · active
Infinite Business Systems Ltd trading as The Service Healthcare shared · · active
Infinite Business Systems Ltd Trading as The Service Healthcare shared £94,750,000 17 Dec 2021 active
Insight Health Limited shared £94,750,000 17 Dec 2021 active
Insight Health Limited shared · · active
Iskus Health UK Ltd shared £94,750,000 17 Dec 2021 active
Iskus Health UK Ltd shared · · active
Macdonald and Taylor Healthcare Limited shared · · active
Macdonald & Taylor Healthcare Limited shared £94,750,000 17 Dec 2021 active
Molnlycke Health Care Limited shared £94,750,000 17 Dec 2021 active
Molnlycke Health Care Limited shared · · active
Optimum Medical Solutions Limited shared · · active
Optimum Medical Solutions Limited Trading as Optimum Medical shared £94,750,000 17 Dec 2021 active
Pal International Limited shared £94,750,000 17 Dec 2021 active
Pal International Limited shared · · active
Paul Hartmann Limited shared £94,750,000 17 Dec 2021 active
Paul Hartmann Limited shared · · active
PDI (EMEA) Ltd shared £94,750,000 17 Dec 2021 active
PDI (EMEA) Ltd shared · · active
Pearmine Health Ltd shared £94,750,000 17 Dec 2021 active
Pearmine Health Ltd shared · · active
Potter & Moore Innovations Limited shared £94,750,000 17 Dec 2021 active
Potter & Moore Innovations Limited shared · · active
Prestige Personal Care Limited shared £94,750,000 17 Dec 2021 active
Prestige Personal Care Limited shared · · active
Procotech Ltd shared £94,750,000 17 Dec 2021 active
Procotech Ltd shared · · active
Prosys International Limited shared £94,750,000 17 Dec 2021 active
Prosys International Limited shared · · active
PTP Healthcare Ltd shared £94,750,000 17 Dec 2021 active
PTP Healthcare Ltd shared · · active
Reliance Medical Ltd shared £94,750,000 17 Dec 2021 active
Reliance Medical Ltd shared · · active
Robinson Healthcare Limited shared £94,750,000 17 Dec 2021 active
Robinson Healthcare Limited shared · · active
Saraco Industries Limited shared £94,750,000 17 Dec 2021 active
Saraco Industries Limited shared · · active
Schulke and Mayr UK Limited shared · · active
Schulke & Mayr UK Limited shared £94,750,000 17 Dec 2021 active

description

The Framework Agreement is for the supply of skin cleansing and disinfection products for patient use, including but not limited to patient cleansing wipes, patient cleansing and hygiene products, localised alcohol skin cleansing and decolonisation wipes, body cleansing and decolonisation products, biocides, and skin disinfection medicinal products.

The Framework Agreement will have an initial term of 36 months with an option to extend incrementally for up to a total period of 48 months.

It is anticipated that in the first 36 months of the Framework Agreement the value of purchases will be in the region of £70,600,000 GBP ex VAT. For the full 48 month term (if

extended) the anticipated value is £94,750,000 GBP ex VAT. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of

growth. The values provided are for guidance only and are not a guarantee of business.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
28 Oct 2020 Tender (tender) · cebda581-5a33-4bbb-bc18-8827ebd1fa1f-389793
30 Mar 2021 Contract notice (F02) Earlier regulations 006462-2021
31 Jan 2022 Contract award notice (F03) Earlier regulations 002764-2022
1 Feb 2022 Award (award) · fd369eeb-5ac5-43bc-aeee-f005b9a2877a-506174

more from NHS Supply Chain

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.